This study analyzed 22 cases of primary oral melanoma through histopathological and immunohistochemical examination. The main findings were:
1) Most cases affected the hard palate and occurred in older adults, with deep levels of invasion seen in most cases.
2) Immunohistochemistry found S-100 and HMB-45 proteins were expressed in all cases, while Melan-A was negative in 3 cases.
3) Proliferation rates measured by Ki-67 were high, ranging from 15.5% to 63% of cells staining positive.
Heinrich_et_al-2003-International_Journal_of_CancerBianca Heinrich
This study investigated the molecular basis of sporadic and familial multiple meningiomas in 7 unrelated patients without clinical evidence of neurofibromatosis type 2 (NF2). Mutational analysis of the NF2 and DAL-1 genes was performed on tumor and blood samples. Truncating NF2 mutations were found in 3 tumors but not blood, and 2 tumors showed loss of the NF2 locus. In contrast, 5 non-truncating changes were found in DAL-1 in both tumor and blood samples, with no loss of the DAL-1 locus. The findings provide evidence that the molecular basis of sporadic and familial multiple meningiomas differs, with NF2 inactivation involved in sporadic
BACKGROUND: Sequential Epstein-Barr virus (EBV)–positive B cell lymphoma to the initial diagnosis of angioimmunoblastic T cell lymphoma (AITL) is very rare, the exact mechanism and standard therapy of which is still being explored. CASE: A 50-year-old man was admitted to our hospital in January 2014 with a three-week history of enlargement of multiple lymph nodes. His initial pathological evaluation indicated AILT. The reactivation of EBV was observed during the immunosuppression therapy for AITL, accompanied by onset of subcutaneous nodules proven to be EBV-positive diffuse large B cell lymphoma (DLBCL) based on the pathological findings of rebiopsy. The patient was successfully treated with chidamide, a histone deacetylase (HDAC) inhibitor, and rituximab.
Conclusion: The sufficient surveillance for serum EBV and repeat biopsy is necessary for patients with AITL, and this treatment modality may become an active option.
Keywords: angioimmunoblastic T cell lymphoma, Epstein-Barr virus, HDAC inhibitor, non-Hodgkin lymphoma, peripheral T cell lymphoma
This review article discusses emerging understanding of tumor heterogeneity at multiple scales. Cancer is characterized by heterogeneous genetic alterations and cellular metabolism at the organ, tissue, and cellular level. Key features of cancer heterogeneity are summarized by the 10 hallmarks of cancer. At the DNA and cellular level, germline and somatic mutations cause abnormal cell behavior and growth. The tumor microenvironment and its components also facilitate or restrict tumor growth. Research is gaining a tremendous surge of comprehension of these disease mechanisms, which will lead to novel drug targets and challenges in drug discovery. Integrated multi-omic technologies are essential tools to understand all the various cellular changes involved in tumorigenesis. The review examines features of cancer heterogeneity and discusses how multiplexed technologies can facilitate
This document contains summaries of several research articles and publications related to the treatment of chronic lymphocytic leukemia using nanoparticles, photodynamic therapy, and mesenchymal stem cells. Many of the publications were authored or co-authored by Eduardo Mansilla and focus on developing new therapeutic approaches for blood cancers using nanotechnology and regenerative medicine techniques.
This study sequenced the genomes of 11 clinical Mycobacterium abscessus isolates from 8 US patients with pulmonary infections. Core genome analysis compared these isolates to 30 globally diverse strains to investigate population structure. Longitudinally sampled isolates showed very few genetic differences, suggesting homogenous infection populations. Genome content variation between isolates was 0.3-8.3% compared to the reference strain, indicating plasticity.
Cytogenetic and Molecular Characterization of Hematological Neoplasm in an Ec...Andresz26
This study characterized the cytogenetic and molecular features of hematological malignancies in an Ecuadorian population. The researchers analyzed over 4,000 patients between 1984-2012, detecting chromosome abnormalities in around 46% via conventional cytogenetics. Specific genetic fusions were also identified, including BCR-ABL (present in 95% of CML patients as the b2/a2 transcript), PML-RARA (showing the bcr2 and bcr3 transcripts but not bcr1), CBFB-MYH11 (all cases exhibited the F transcript), and MLL-AF4 (all cases displayed the e7-e8 transcript). The frequencies of some fusion gene subtypes differed from
Continuous Exposure to Chrysotile Asbestos Can CauseGhazal Khan
This document summarizes a study that found continuous exposure to chrysotile asbestos can induce transformation of human mesothelial cells through signaling of HMGB1 and TNF-α, similar to effects of crocidolite asbestos exposure. Both asbestos types induced epithelial-to-mesenchymal transition in cells, characterized by downregulation of E-cadherin and phosphorylation/nuclear translocation of β-catenin. While crocidolite exposure induced sustained gene expression changes and HMGB1 release, chrysotile effects returned to baseline within 5-8 weeks. Continuous chrysotile exposure was required to maintain elevated HMGB1 levels, supporting the role of fiber persistence in biological activity.
1) The study examined samples of benign oral squamous cell carcinoma (BOSC) and oral squamous cell carcinoma (OSCC) to determine the incidence of HPV infection and mutations in p53 and c-myc genes.
2) It found that 23% of BOSC samples and 73% of OSCC samples had HPV infections. All BOSC samples with HPV infection showed no mutations in p53 or c-myc genes, while 81% of OSCC samples with HPV infection had no p53 mutation and 91% had no c-myc mutation.
3) Statistical analysis revealed significant differences between BOSC and OSCC groups in terms of HPV infection without mutations in p53 and
Heinrich_et_al-2003-International_Journal_of_CancerBianca Heinrich
This study investigated the molecular basis of sporadic and familial multiple meningiomas in 7 unrelated patients without clinical evidence of neurofibromatosis type 2 (NF2). Mutational analysis of the NF2 and DAL-1 genes was performed on tumor and blood samples. Truncating NF2 mutations were found in 3 tumors but not blood, and 2 tumors showed loss of the NF2 locus. In contrast, 5 non-truncating changes were found in DAL-1 in both tumor and blood samples, with no loss of the DAL-1 locus. The findings provide evidence that the molecular basis of sporadic and familial multiple meningiomas differs, with NF2 inactivation involved in sporadic
BACKGROUND: Sequential Epstein-Barr virus (EBV)–positive B cell lymphoma to the initial diagnosis of angioimmunoblastic T cell lymphoma (AITL) is very rare, the exact mechanism and standard therapy of which is still being explored. CASE: A 50-year-old man was admitted to our hospital in January 2014 with a three-week history of enlargement of multiple lymph nodes. His initial pathological evaluation indicated AILT. The reactivation of EBV was observed during the immunosuppression therapy for AITL, accompanied by onset of subcutaneous nodules proven to be EBV-positive diffuse large B cell lymphoma (DLBCL) based on the pathological findings of rebiopsy. The patient was successfully treated with chidamide, a histone deacetylase (HDAC) inhibitor, and rituximab.
Conclusion: The sufficient surveillance for serum EBV and repeat biopsy is necessary for patients with AITL, and this treatment modality may become an active option.
Keywords: angioimmunoblastic T cell lymphoma, Epstein-Barr virus, HDAC inhibitor, non-Hodgkin lymphoma, peripheral T cell lymphoma
This review article discusses emerging understanding of tumor heterogeneity at multiple scales. Cancer is characterized by heterogeneous genetic alterations and cellular metabolism at the organ, tissue, and cellular level. Key features of cancer heterogeneity are summarized by the 10 hallmarks of cancer. At the DNA and cellular level, germline and somatic mutations cause abnormal cell behavior and growth. The tumor microenvironment and its components also facilitate or restrict tumor growth. Research is gaining a tremendous surge of comprehension of these disease mechanisms, which will lead to novel drug targets and challenges in drug discovery. Integrated multi-omic technologies are essential tools to understand all the various cellular changes involved in tumorigenesis. The review examines features of cancer heterogeneity and discusses how multiplexed technologies can facilitate
This document contains summaries of several research articles and publications related to the treatment of chronic lymphocytic leukemia using nanoparticles, photodynamic therapy, and mesenchymal stem cells. Many of the publications were authored or co-authored by Eduardo Mansilla and focus on developing new therapeutic approaches for blood cancers using nanotechnology and regenerative medicine techniques.
This study sequenced the genomes of 11 clinical Mycobacterium abscessus isolates from 8 US patients with pulmonary infections. Core genome analysis compared these isolates to 30 globally diverse strains to investigate population structure. Longitudinally sampled isolates showed very few genetic differences, suggesting homogenous infection populations. Genome content variation between isolates was 0.3-8.3% compared to the reference strain, indicating plasticity.
Cytogenetic and Molecular Characterization of Hematological Neoplasm in an Ec...Andresz26
This study characterized the cytogenetic and molecular features of hematological malignancies in an Ecuadorian population. The researchers analyzed over 4,000 patients between 1984-2012, detecting chromosome abnormalities in around 46% via conventional cytogenetics. Specific genetic fusions were also identified, including BCR-ABL (present in 95% of CML patients as the b2/a2 transcript), PML-RARA (showing the bcr2 and bcr3 transcripts but not bcr1), CBFB-MYH11 (all cases exhibited the F transcript), and MLL-AF4 (all cases displayed the e7-e8 transcript). The frequencies of some fusion gene subtypes differed from
Continuous Exposure to Chrysotile Asbestos Can CauseGhazal Khan
This document summarizes a study that found continuous exposure to chrysotile asbestos can induce transformation of human mesothelial cells through signaling of HMGB1 and TNF-α, similar to effects of crocidolite asbestos exposure. Both asbestos types induced epithelial-to-mesenchymal transition in cells, characterized by downregulation of E-cadherin and phosphorylation/nuclear translocation of β-catenin. While crocidolite exposure induced sustained gene expression changes and HMGB1 release, chrysotile effects returned to baseline within 5-8 weeks. Continuous chrysotile exposure was required to maintain elevated HMGB1 levels, supporting the role of fiber persistence in biological activity.
1) The study examined samples of benign oral squamous cell carcinoma (BOSC) and oral squamous cell carcinoma (OSCC) to determine the incidence of HPV infection and mutations in p53 and c-myc genes.
2) It found that 23% of BOSC samples and 73% of OSCC samples had HPV infections. All BOSC samples with HPV infection showed no mutations in p53 or c-myc genes, while 81% of OSCC samples with HPV infection had no p53 mutation and 91% had no c-myc mutation.
3) Statistical analysis revealed significant differences between BOSC and OSCC groups in terms of HPV infection without mutations in p53 and
This document summarizes current status of biomarkers for potentially malignant oral disorders (PMODs) and oral squamous cell carcinomas (OSCCs), with an emphasis on the specificity and sensitivity of serum and salivary biomarkers. It discusses that traditional diagnosis has limitations and biomarkers can help overcome these issues. The document defines biomarkers and describes different types, including tumor markers. It evaluates several potential salivary and serum biomarkers for PMODs and OSCCs, finding that many lack sufficient specificity or sensitivity for clinical use. Overall biomarkers show promise for non-invasive screening and diagnosis but further validation is still needed.
The Prognostic Value of Nucleolar Organiser Regions in Colorectal CancerMichelle Fynes
Nucleolar organiser regions (AgNORs) are loops of ribosomal DNA which reflect the cellular activity or malignant potential of the cell and are identified by a specific staining technique. The purpose of this study was to assess the prognostic value of AgNORs in colorectal cancer and to compare it with other accepted prognostic methods.
1) The human JC virus (JCV) infects over 80% of humans and is associated with the fatal demyelinating disease progressive multifocal leukoencephalopathy (PML).
2) JCV has the ability to transform cells in culture and induce tumors in animal models. Its major oncoprotein, T-antigen, interacts with tumor suppressors like p53 and Rb to deregulate pathways controlling cell proliferation.
3) Studies suggest T-antigen promotes tumorigenesis by interacting with cellular proteins involved in proliferation signaling like IRS-1, disrupting tumor suppressor functions and activating pathways like IGF-1 signaling.
Field cancerization refers to genetic and molecular alterations that occur in histologically normal tissue surrounding tumors. These alterations predispose the tissue to developing additional new cancers. The document discusses two cases presenting with multiple primary tumors in the oral cavity and larynx as examples of field cancerization. It then reviews the original description of field cancerization from 1953 and various theories for how it occurs. The concept of an "etiologic field effect" is introduced, which broadens the understanding of cancer susceptibility at the molecular, cellular and environmental levels. Several examples of field cancerization are described for different cancer types. Clinical tools for detecting field cancerization like iodine staining and toluidine blue staining are also mentioned.
This article summarizes 9 research papers on gene and cell therapy approaches for treating cystic fibrosis. It provides brief summaries of the objectives, methods, and conclusions of each paper to give an overview of the current state of research on developing therapies for cystic fibrosis.
For quiet a long time now there has been no treatment for metastatic colon cancer patients beyond second line except Regorafenib and TAS 103 which have shown some effectiveness but not long lasting and in recent times Immunotherapy in colon cancer has opened a new field of treatment where patients with MSI-H do well and survive for longer time.And in few patients there is a complete response. 9810619717. Initialyy pemrolizumab was approved but now nivolumab is approved as well.But the irony is that only 2 out of 17 patients were MSI-H at our centre.
Targeted sequencing of 99 colorectal cancer samples identified frequent mutations in TP53 (65%), APC (36%), KRAS (35%), PIK3CA (19%), and other genes. EGFR mutations were associated with younger age of onset. EGFR or PIK3CA mutations were markers of poor disease-specific survival, and KRAS or PIK3CA mutations were associated with poor survival in TP53 wild-type cases. The findings provide novel prognostic insights and could help clinical decision-making for colorectal cancer patients in Saudi Arabia.
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement M Dominici1, K Le Blanc2, I Mueller3, I Slaper-Cortenbach4, FC Marini5, DS Krause6, RJ Deans7, A Keating8, DJ Prockop9 and EM Horwitz10
My first proposal, Everyone knows a person that have or had Cancer. We know that Cancer dosen't have a cure an yet the therapies for it, sometimes, do more harm to the person because the therapy do not choose what kind of cell is going to destroy. But if we can develop a new kind of treatment, a less agresive and more effective one, we will increase the survival chances and minimizes the secondary efects.
The Role of Osteopontin Expression in the Prognosis of Malignant Melanoma_Cri...CrimsonpublishersCancer
Malignant melanoma is the most aggressive type of skin cancer, and its prevalence is gradually increasing worldwide [1]. Despite the significant steps taken towards understanding the mechanism of progression of melanoma, non-surgical treatment options are limited. New therapeutic targets and diagnostic tools are required for cases of malignant melanoma, considering its poor prognosis.
Colon Cancer PDX Organoids and Cell LinesSean Maden
This document describes the establishment of colorectal cancer (CRC) patient-derived xenograft (PDX) lines and PDX-derived organoids at Fred Hutchinson Cancer Research Center. Two CRC PDX lines (CRC114 and CRC125) were established and their histological features and mutations were analyzed and found to be stable over passages in mice. Organoids were also derived from the PDX tumors that maintained the characteristics of the original tumor. The goal was to create accurate preclinical CRC models to facilitate personalized therapy and study CRC biology.
This document describes the characterization of a new head and neck squamous cell carcinoma (HNSCC) cell line called USC-HN2. USC-HN2 was established from a patient with recurrent oral cavity cancer. Characterization showed USC-HN2 has properties typical of aggressive oral HNSCC, including expression of markers like EGFR, CD44v6, and FABP5. Testing revealed USC-HN2 strongly induces regulatory T cells and myeloid-derived suppressor cells in vitro, suggesting an immunosuppressive phenotype. Comparison to another HNSCC cell line, SCCL-MT1, showed both lines have robust cytokine production and immune cell induction, making them useful models for
Ong et al._Translational utility of next-generation sequencing_2013_GenomicsFrank Ong, MD, CPI
Next-generation sequencing (NGS) has made DNA sequencing rapid, cost-effective and highly accurate. NGS has translational utility in several areas: 1) It can detect genetic variations associated with disease risk and treatment response; 2) It enables non-invasive prenatal testing for fetal abnormalities; 3) Cancer genome sequencing can improve diagnosis, prognosis and treatment by deciphering a cancer's genetic makeup. NGS also has utility in rare genetic disease diagnosis and in precision medicine by matching patients to targeted therapies.
The document discusses four main strategies for monitoring the efficacy of oncolytic viruses via gene expression analysis: 1) analyzing overall gene expression in tumor cells before and after virus treatment, 2) looking at specific genes in tumor cells, 3) focusing on transgenes introduced into viruses, and 4) following viral gene expression. Several studies utilized these approaches in animal models and human cell lines. Gene expression changes provided insights into mechanisms like apoptosis, immune response, and signaling pathways affected. The most informative monitoring may integrate analysis of tumor cell and viral gene expression over time.
Yayan T. Sundara, Dokter di Klinik Jejaring Padjadjaran dan Master of Bio Medical Science Research dari Leiden University Medical Centrum, juga staff Departemen Pelayanan PT Rumah Sakit Padjadjaran
This study used high-density SNP microarrays to analyze chromosomal changes in 86 paired colorectal cancer and normal tissue samples from Bangladeshi patients. The researchers identified common regions of amplification on chromosomes 20q, 13q, 8q, and 5p and deletions on 18q, 17p, and 8p. They also detected mosaicism and different types of chromosomal abnormalities that could not be assessed by other methods. By matching genes in altered regions to drug databases, the researchers identified potential targeted therapies for personalized treatment based on a patient's cytogenetic profile. This represents an application of high-density SNP arrays for colorectal cancer cytogenetics and personalized treatment approaches.
This document compares risk factors and molecular analysis of right-sided colon cancer and left-sided colon cancer. It discusses that:
- Right-sided colon cancer predominantly follows a MSI pathway while left-sided colon cancer follows a CIN pathway.
- There are differences in the embryonic development, function, and gene expression between the right and left colon that influence cancer risk.
- Certain risk factors like family history, inflammatory bowel disease, diet, and geographic location are associated with increased rates of either right-sided or left-sided colon cancers.
Thymomas in Fischer 344N Rats in The National Toxicology Program DatabaseEPL, Inc.
Thymomas are rare tumors in F344/N rats. This study summarizes 277 thymomas from NTP studies. Most thymomas were benign (84.8%) and showed heterogeneous morphology but were categorized into 6 patterns. Malignant thymomas comprised 15.2% and were diagnosed based on invasion, metastasis, or cytology. Malignant thymomas were associated with shorter survival times. While morphology varied, there was no correlation with behavior. Classification into benign vs malignant adequately describes thymomas in F344/N rats.
Conferencia de la Dra. Ana María Roa, Bióloga Molecular, sobre Epigenética, impartida en la Universidad Popular Carmen de Michelena de Tres Cantos el 1 de marzo de 2013.
Más información en:
http://www.universidadpopularc3c.es/index.php/actividades/conferencias/event/448-conferencia-una-revision-de-los-conocimientos-fundamentales-de-la-biologia-de-la-celula-la-epigenetica
This document summarizes current status of biomarkers for potentially malignant oral disorders (PMODs) and oral squamous cell carcinomas (OSCCs), with an emphasis on the specificity and sensitivity of serum and salivary biomarkers. It discusses that traditional diagnosis has limitations and biomarkers can help overcome these issues. The document defines biomarkers and describes different types, including tumor markers. It evaluates several potential salivary and serum biomarkers for PMODs and OSCCs, finding that many lack sufficient specificity or sensitivity for clinical use. Overall biomarkers show promise for non-invasive screening and diagnosis but further validation is still needed.
The Prognostic Value of Nucleolar Organiser Regions in Colorectal CancerMichelle Fynes
Nucleolar organiser regions (AgNORs) are loops of ribosomal DNA which reflect the cellular activity or malignant potential of the cell and are identified by a specific staining technique. The purpose of this study was to assess the prognostic value of AgNORs in colorectal cancer and to compare it with other accepted prognostic methods.
1) The human JC virus (JCV) infects over 80% of humans and is associated with the fatal demyelinating disease progressive multifocal leukoencephalopathy (PML).
2) JCV has the ability to transform cells in culture and induce tumors in animal models. Its major oncoprotein, T-antigen, interacts with tumor suppressors like p53 and Rb to deregulate pathways controlling cell proliferation.
3) Studies suggest T-antigen promotes tumorigenesis by interacting with cellular proteins involved in proliferation signaling like IRS-1, disrupting tumor suppressor functions and activating pathways like IGF-1 signaling.
Field cancerization refers to genetic and molecular alterations that occur in histologically normal tissue surrounding tumors. These alterations predispose the tissue to developing additional new cancers. The document discusses two cases presenting with multiple primary tumors in the oral cavity and larynx as examples of field cancerization. It then reviews the original description of field cancerization from 1953 and various theories for how it occurs. The concept of an "etiologic field effect" is introduced, which broadens the understanding of cancer susceptibility at the molecular, cellular and environmental levels. Several examples of field cancerization are described for different cancer types. Clinical tools for detecting field cancerization like iodine staining and toluidine blue staining are also mentioned.
This article summarizes 9 research papers on gene and cell therapy approaches for treating cystic fibrosis. It provides brief summaries of the objectives, methods, and conclusions of each paper to give an overview of the current state of research on developing therapies for cystic fibrosis.
For quiet a long time now there has been no treatment for metastatic colon cancer patients beyond second line except Regorafenib and TAS 103 which have shown some effectiveness but not long lasting and in recent times Immunotherapy in colon cancer has opened a new field of treatment where patients with MSI-H do well and survive for longer time.And in few patients there is a complete response. 9810619717. Initialyy pemrolizumab was approved but now nivolumab is approved as well.But the irony is that only 2 out of 17 patients were MSI-H at our centre.
Targeted sequencing of 99 colorectal cancer samples identified frequent mutations in TP53 (65%), APC (36%), KRAS (35%), PIK3CA (19%), and other genes. EGFR mutations were associated with younger age of onset. EGFR or PIK3CA mutations were markers of poor disease-specific survival, and KRAS or PIK3CA mutations were associated with poor survival in TP53 wild-type cases. The findings provide novel prognostic insights and could help clinical decision-making for colorectal cancer patients in Saudi Arabia.
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement M Dominici1, K Le Blanc2, I Mueller3, I Slaper-Cortenbach4, FC Marini5, DS Krause6, RJ Deans7, A Keating8, DJ Prockop9 and EM Horwitz10
My first proposal, Everyone knows a person that have or had Cancer. We know that Cancer dosen't have a cure an yet the therapies for it, sometimes, do more harm to the person because the therapy do not choose what kind of cell is going to destroy. But if we can develop a new kind of treatment, a less agresive and more effective one, we will increase the survival chances and minimizes the secondary efects.
The Role of Osteopontin Expression in the Prognosis of Malignant Melanoma_Cri...CrimsonpublishersCancer
Malignant melanoma is the most aggressive type of skin cancer, and its prevalence is gradually increasing worldwide [1]. Despite the significant steps taken towards understanding the mechanism of progression of melanoma, non-surgical treatment options are limited. New therapeutic targets and diagnostic tools are required for cases of malignant melanoma, considering its poor prognosis.
Colon Cancer PDX Organoids and Cell LinesSean Maden
This document describes the establishment of colorectal cancer (CRC) patient-derived xenograft (PDX) lines and PDX-derived organoids at Fred Hutchinson Cancer Research Center. Two CRC PDX lines (CRC114 and CRC125) were established and their histological features and mutations were analyzed and found to be stable over passages in mice. Organoids were also derived from the PDX tumors that maintained the characteristics of the original tumor. The goal was to create accurate preclinical CRC models to facilitate personalized therapy and study CRC biology.
This document describes the characterization of a new head and neck squamous cell carcinoma (HNSCC) cell line called USC-HN2. USC-HN2 was established from a patient with recurrent oral cavity cancer. Characterization showed USC-HN2 has properties typical of aggressive oral HNSCC, including expression of markers like EGFR, CD44v6, and FABP5. Testing revealed USC-HN2 strongly induces regulatory T cells and myeloid-derived suppressor cells in vitro, suggesting an immunosuppressive phenotype. Comparison to another HNSCC cell line, SCCL-MT1, showed both lines have robust cytokine production and immune cell induction, making them useful models for
Ong et al._Translational utility of next-generation sequencing_2013_GenomicsFrank Ong, MD, CPI
Next-generation sequencing (NGS) has made DNA sequencing rapid, cost-effective and highly accurate. NGS has translational utility in several areas: 1) It can detect genetic variations associated with disease risk and treatment response; 2) It enables non-invasive prenatal testing for fetal abnormalities; 3) Cancer genome sequencing can improve diagnosis, prognosis and treatment by deciphering a cancer's genetic makeup. NGS also has utility in rare genetic disease diagnosis and in precision medicine by matching patients to targeted therapies.
The document discusses four main strategies for monitoring the efficacy of oncolytic viruses via gene expression analysis: 1) analyzing overall gene expression in tumor cells before and after virus treatment, 2) looking at specific genes in tumor cells, 3) focusing on transgenes introduced into viruses, and 4) following viral gene expression. Several studies utilized these approaches in animal models and human cell lines. Gene expression changes provided insights into mechanisms like apoptosis, immune response, and signaling pathways affected. The most informative monitoring may integrate analysis of tumor cell and viral gene expression over time.
Yayan T. Sundara, Dokter di Klinik Jejaring Padjadjaran dan Master of Bio Medical Science Research dari Leiden University Medical Centrum, juga staff Departemen Pelayanan PT Rumah Sakit Padjadjaran
This study used high-density SNP microarrays to analyze chromosomal changes in 86 paired colorectal cancer and normal tissue samples from Bangladeshi patients. The researchers identified common regions of amplification on chromosomes 20q, 13q, 8q, and 5p and deletions on 18q, 17p, and 8p. They also detected mosaicism and different types of chromosomal abnormalities that could not be assessed by other methods. By matching genes in altered regions to drug databases, the researchers identified potential targeted therapies for personalized treatment based on a patient's cytogenetic profile. This represents an application of high-density SNP arrays for colorectal cancer cytogenetics and personalized treatment approaches.
This document compares risk factors and molecular analysis of right-sided colon cancer and left-sided colon cancer. It discusses that:
- Right-sided colon cancer predominantly follows a MSI pathway while left-sided colon cancer follows a CIN pathway.
- There are differences in the embryonic development, function, and gene expression between the right and left colon that influence cancer risk.
- Certain risk factors like family history, inflammatory bowel disease, diet, and geographic location are associated with increased rates of either right-sided or left-sided colon cancers.
Thymomas in Fischer 344N Rats in The National Toxicology Program DatabaseEPL, Inc.
Thymomas are rare tumors in F344/N rats. This study summarizes 277 thymomas from NTP studies. Most thymomas were benign (84.8%) and showed heterogeneous morphology but were categorized into 6 patterns. Malignant thymomas comprised 15.2% and were diagnosed based on invasion, metastasis, or cytology. Malignant thymomas were associated with shorter survival times. While morphology varied, there was no correlation with behavior. Classification into benign vs malignant adequately describes thymomas in F344/N rats.
Conferencia de la Dra. Ana María Roa, Bióloga Molecular, sobre Epigenética, impartida en la Universidad Popular Carmen de Michelena de Tres Cantos el 1 de marzo de 2013.
Más información en:
http://www.universidadpopularc3c.es/index.php/actividades/conferencias/event/448-conferencia-una-revision-de-los-conocimientos-fundamentales-de-la-biologia-de-la-celula-la-epigenetica
This document discusses motivation in the workplace. It defines motivation as the internal drive to accomplish goals. Motivation makes employees want to work. There are two main types of motivation: intrinsic motivation that comes from within such as acceptance and curiosity, and extrinsic motivation that comes from outside rewards like money and bonuses. Several theories of motivation are described, including Maslow's hierarchy of needs from physiological to self-actualization, Alderfer's ERG theory of existence, relatedness and growth needs, and McClelland's need theory focused on achievement, power and affiliation. Maintaining motivation is important for high performance, low turnover, better organizational image and industrial relations.
This letter provides a glowing recommendation for Andrea McLemore. The writer worked alongside Ms. McLemore for nine years as her direct supervisor and has known her for a total of fifteen years. As administrator of the Jung Educational Center of Houston, Ms. McLemore managed finances, maintained the building, supervised staff, and interacted with the public, performing all duties accurately and efficiently. The staff and public enjoyed working with her. There were never any complaints about her work or behavior. The writer gives his highest recommendation for Ms. McLemore and believes she will bring competence, dignity, and camaraderie to any workplace.
Automating Networks by Converting into API/WebsAPNIC
Automating Networks by Converting into API/Webs, by Issei Inoue.
A presentation given at APRICOT 2016’s Network Infrastructure session on 24 February 2016.
Mucoepidermoid carcinoma (Doctor Faris Alabeedi MSc, MMedSc, PgDip, BDS.)Doctor Faris Alabeedi
Mucoepidermoid carcinoma is the most common malignant salivary gland tumor. It is composed of mucinous, intermediate, and squamoid cells forming cystic and solid patterns. It most commonly occurs in the parotid and palate and affects a wide age range, though it is more common in the second decade of life. Low and intermediate grade mucoepidermoid carcinomas have a good prognosis after surgical excision, with 10-year survival rates of 90% and 70% respectively. High grade tumors have a poorer prognosis of 25% 10-year survival. The presence of the CRTC1-MAML2 gene fusion correlates with lower grade tumors and a better prognosis.
This document presents 3 dermatology cases seen by Dr. Maha Assem Fahmy. Case 1 involves a 4-year-old male child with perianal lesions diagnosed as Langerhans cell histiocytosis through biopsy. Case 2 is a 42-year-old man with a skin-colored nodule on his cheek diagnosed as diffuse large B-cell lymphoma. Case 3 describes a 30-year-old woman with nodules on her face and eyebrows diagnosed as tumid lupus erythematosus through serological tests and direct immunofluorescence. Each case discusses treatment and provides literature to support diagnoses and management approaches.
Cutaneous expression of TREM, vitamin D receptor and HMGB1 in vitamin D defic...Jonathan Fleegel
This study examined the expression of TREM-1, TREM-2, VDR, HMGB1, and RAGE in the skin of vitamin D deficient and sufficient pigs. The researchers found that in vitamin D sufficient animals, keratinocytes exhibited higher levels of TREM-1 and TREM-2 compared to deficient animals. TREM-1 expression was higher in basal cells, while TREM-2 levels were higher in keratinocytes, regardless of vitamin D state. Levels of HMGB1 and RAGE did not differ based on vitamin D state. VDR expression was consistently higher in basal cell nuclei and cytoplasm compared to keratinocytes. The findings suggest vitamin D signaling may play a role in T
This study analyzed canine haemangioma and haemangiosarcoma samples immunohistochemically to better characterize the biology and identify potential therapeutic targets. It found greater expression of CD117, VEGFR-3 and CD44 in haemangiosarcoma compared to haemangioma, suggesting these proteins may be suitable targets. It also found marked mast cell infiltration in haemangioma, indicating a possible role for mast cells in benign vascular neoplasia in dogs.
Histopathological patterns of cutaneous malignant melanoma in Sudaniosrjce
This study aimed to determine the histopathological patterns of cutaneous malignant melanoma in Sudanese patients. The study found that males represented 57.1% of cases and the majority of lesions (81.6%) were on the lower limbs. The most common clinic-pathological type was acral-lentiginous melanoma (75.5%). Microscopy showed epithelioid cell type in 61.2% of cases and deep invasion, ulceration, and lymphovascular invasion were common, indicating late stage at presentation. The findings were similar to previous studies in other African populations.
EXPRESSION OF CK5 BASAL CYTOKERATIN DURING METASTATIC DEVELOPMENT OF BREAST C...ANCA MARIA CIMPEAN
Objective. Breast cancer is a one of the most common cancers in females worldwide. Basal cytokeratin CK5 represent the marker of progenitors for glandular and myoepithelial lineages of mammary epithelium. During epithelial differentiation there is a gradual decrease of CK5 expression. The purpose of this study was to compare the expression of basal cytokeratin CK5 vs hormone receptors, HER2, Ki67 and molecular subtypes immunohistochemically defined in the primary breast carcinoma of NST type and axillar lymph node metastasis. Material and Methods. We processed immunohistochemically 91 invasive breast carcinomas of NST type and their ipsilateral axillar lymph node metastasis (LNM). Results. The majority of primary tumors were evaluated as CK5 negative (78 cases/85.7%). The majority of cases were evaluated as Luminal B (50 cases/54.9%) and Luminal A (28 cases/30.8%) tumors. The HER2 subtype was confirmed in 8 cases/8.8%, 5NP in 3 cases/3.3% and Basal-like in 2 cases/2.2%. The parallel comparison of CK5 expression at both sites, primary and metastatic, revealed that this marker is not stable during metastatic progression. The molecular subtypes were not stable during metastatic process in 21 cases/23.1%. Conclusions. The majority of NST invasive ductal breast carcinomas are CK5 negative. The molecular subtypes and CK5 are not stable during metastatic process. Cancerous cells prefer to lose this marker in the lymph node environment. The presence of cases with simultaneous expression of CK5 and hormone receptors is an open field to debate the existence of other, transient molecular subtypes. We expect a further confirmation in larger study groups.
Key Words: molecular subtypes, invasive carcinoma NST type, basal cytokeratin.
This study aimed to determine if mutations in the human cystatin M/E gene (CST6) contribute to harlequin ichthyosis (HI) by sequencing the entire coding region and intron-exon boundaries of CST6 in 11 patients with HI. No mutations were found in CST6, indicating it is not a major gene for types 1 and 2 HI. However, cystatin M/E protein expression was normal in patient tissues by immunohistochemistry, suggesting regulatory or noncoding mutations were unlikely. While CST6 does not appear to cause HI, further study of its role in skin differentiation and other skin disorders may provide insights into cornification pathways.
1. Researchers developed a new cell line called DEN-HSA derived from a spontaneous hemangiosarcoma in a dog.
2. Characterization showed DEN-HSA cells express markers of endothelial cells and form tube-like structures in vitro. They also secrete factors that strongly stimulate angiogenesis.
3. The DEN-HSA cell line maintains features of angiogenic endothelium and could be useful for studying novel therapies that target endothelial proliferation involved in diseases like cancer.
This document summarizes the case of a 4-year-old male child who presented with perianal lesions for 3 months. A biopsy was performed and found dermal infiltration of Langerhans cells, indicating a diagnosis of Langerhans cell histiocytosis (LCH). Imaging and bloodwork found no evidence of systemic involvement. The patient was treated with imiquimod 5% cream for 2 weeks, which resulted in complete resolution of the lesions. Perianal LCH is rare, with only 17 previous cases reported in the literature. This case highlights the importance of documenting and publishing unusual clinical presentations that can advance medical knowledge.
This study analyzed loss of heterozygosity (LOH) in papillary thyroid carcinoma (PTC) by examining microsatellite markers in the M6P/IGFIIR gene region and three loci on chromosome 11 in 98 PTC tumor and normal tissue samples. The samples showed 49-63% heterozygosity for the markers analyzed. However, LOH was not detected in any of the informative heterozygous samples, indicating that LOH did not contribute to PTC development in these patients for the regions studied.
This document outlines the history and mechanisms of the indoleamine-2,3-dioxygenase (IDO) pathway and its role in cancer immunotherapy. It discusses key findings such as:
1) Munn's 1999 discovery that IDO suppresses T-cell mediated rejection of tumors and fetal allografts by depleting tryptophan.
2) Mechanistic studies showing IDO induces T-cell arrest and inhibits proliferation through tryptophan depletion and kynurenine production, leading to Treg differentiation and CTL inhibition.
3) Preclinical studies combining IDO inhibitors with chemotherapy or vaccines, showing enhanced anti-tumor effects.
4) Ongoing clinical
The document discusses molecular subtyping of breast cancer through gene expression profiling which has identified major subtypes including luminal A, luminal B, HER2-enriched, and basal-like. It describes the characteristic gene expressions and clinical features of each subtype. Molecular subtyping is shown to have prognostic and predictive relevance for breast cancer outcomes and treatment responses.
Clinicomycological profile of Dermatophytosis in a teaching hospitalinventionjournals
International Journal of Pharmaceutical Science Invention (IJPSI) is an international journal intended for professionals and researchers in all fields of Pahrmaceutical Science. IJPSI publishes research articles and reviews within the whole field Pharmacy and Pharmaceutical Science, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online.
Whiteman et al-1998-international_journal_of_cancerSilvina Verna
This study investigated the relationship between p53 expression and risk factors for cutaneous melanoma using a case-control study design. Tissue samples from 121 melanoma cases were analyzed for p53 expression using immunohistochemistry. Abnormal p53 expression was detected in 22 samples (18%). Risk factors for p53-positive melanoma included an inability to tan and history of non-melanoma skin cancer. Risk factors for p53-negative melanoma included high nevus count and heavy freckling. The results suggest there may be two pathways in melanoma pathogenesis characterized by p53 overexpression related to chronic sun exposure and pigment cell instability.
Genetic Resistance to Infectious Diseases in the Era of Personalized Medicine...CrimsonpublishersCJMI
Genetic Resistance to Infectious Diseases in the Era of Personalized Medicine by Andrei Alimov in Cohesive Journal of Microbiology & Infectious Disease
This study aimed to evaluate whether the maturation index, calculated based on nuclear area measurements of melanocytes in the upper and lower parts of lesions, can help differentiate challenging melanocytic lesions. The researchers measured nuclear areas in 32 invasive cutaneous melanomas, 35 dysplastic nevi, and 31 benign nevi immunostained with Sox10. They found statistically significant differences in the mean maturation index between melanomas and dysplastic nevi and between melanomas and benign nevi. However, pseudo-maturation in melanomas was not associated with survival outcomes. The study concludes that the maturation index may help in differential diagnosis but has limitations for some melanoma subtypes.
This research article assessed the cytotoxic activity of essential oils from rosemary, turmeric, and ginger plants against cervical cancer (HeLa) cells. Turmeric (CEO) and ginger (GEO) essential oils exhibited potent cytotoxicity, with CEO having an IC50 of 36.6 μg/mL and GEO an IC50 of 129.9 μg/mL. Cell morphology analysis revealed CEO and GEO treated cells displayed chromatin condensation, membrane blebbing, and cell content leakage at concentrations as low as 32.81 μg/mL for CEO and 32.12 μg/mL for GEO. An Annexin V assay further showed CEO and GEO induced cell death through apoptosis. The results suggest CEO and GEO have cytotoxic effects in vitro
Clinical-Pathological Analysis of 37 Oral Squamous Cell Carcinomas in Tucumán...semualkaira
Oral squamous cell carcinoma (OSCC) represents 3% of all malignant neoplasms. Considering the observed regional occurrence of
OSCC, the aim of this study was to analyze the incidence and clinical characteristics of patients with primary carcinoma of the oral
cavity diagnosed in the province of Tucumán, in the Northwestern
of Argentina, where habits and lifestyle can play a central role in
its incidence.
Clinical-Pathological Analysis of 37 Oral Squamous Cell Carcinomas in Tucumán...semualkaira
Oral squamous cell carcinoma (OSCC) represents 3% of all malignant neoplasms. Considering the observed regional occurrence of
OSCC, the aim of this study was to analyze the incidence and clinical characteristics of patients with primary carcinoma of the oral
cavity diagnosed in the province of Tucumán, in the Northwestern
of Argentina, where habits and lifestyle can play a central role in
its incidence.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
One health condition that is becoming more common day by day is diabetes.
According to research conducted by the National Family Health Survey of India, diabetic cases show a projection which might increase to 10.4% by 2030.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
2. Med Oral Patol Oral Cir Bucal. 2012 May 1;17 (3):e383-8. Primary oral melanoma
e384
Introduction
Melanoma is formed by malignant melanocytes, which are
cells derived from the neural crest that produce melanin
(1). Over 90% of melanomas occur in the skin, but they
may also arise from mucosal surfaces or at other sites
wherein neural crest migrate (1,2). Primary oral melano-
mas are rare, comprising 0.4-1.8% of all melanomas and
0.5% of oral malignances (3-5). Primary OM is more com-
mon in the palate and gingiva of adult patients, and initially
asymptomatic contributing to the delay of diagnosis (6-10).
Clinical features vary, but the most common presentation
is an initial dark blue or black irregular macule, turning
later to an ulcerated black nodule (4,10-12).
As in other types of melanomas, the histology of OM
is variable. Basically it is considered three patterns, in
situ, invasive and mixed, the latter is the most common
corresponding to about 55% of the cases (4,12). The
tumor is formed by epithelioid, spindle and plasmacy-
toid tumor cells arranged in a sheet-like, organoid, al-
veolar, solid or desmoplastic configuration (4,5,12,13).
Most primary OM are heavily pigmented, but some are
amelanotic and immunohistochemistry can be helpful
to confirm the diagnosis of these cases (14-25).
The aim of this study is to describe the histological character-
istics and expression of S-100, HMB-45, Melan-A and Ki-67
in 22 cases of primary OM of Latin American patients.
Materials and Methods
Formalin-fixed, paraffin-embedded tissue blocks were
obtained from 22 patients (8 men and 14 women, mean
age 58 years, range of 23-86 years) with primary OM.
Eleven cases were from Guatemala, 7 from Mexico, and
4 from Peru. Of the 22 OM, seven (31.82%) were locat-
ed on the hard palate, five (22.73%) on hard palate and
upper gingiva, four (18.18%) only on the upper gingiva,
and two each (9.09%), on hard and soft palate, on the
lower gingiva and on the buccal mucosa (Fig. 1).
Diagnosis of primary OM was confirmed by the clinical
and histological characteristics, excluding the presence of
melanoma at other anatomical sites and consequently the
possibility of oral metastasis. The parameters evaluated
included presence or absence of melanin in the tumor
(melanotic or amelanotic), level of tumor cells invasion,
cellular morphology (epithelioid, spindle, plasmacytoid
or mixed) and pattern (solid, alveolar, organoid or paget-
oid), necrosis, perineural and perivascular invasion.
Cellular invasion was considered according to Prasad et
al. (26) as noninvasive (in situ), microinvasive (level I, cell
clusters in the superficial lamina propria), invasive (level
II, cell invasion into the lamina propria), and deep invasive
(level III, invasion into skeletal muscle, bone or cartilage).
For immunohistochemical staining three-micrometer-
thick sections were used. Briefly, after antigen retrieval
with EDTA/Tris buffer (pH 9.0) in a microwave oven,
endogenous peroxidase activity was blocked with 20%
H2
O2
for 5 cycles of 5 minutes each. Primary antibodies
(Table 1), after overnight incubation, were detected by
secondary antibodies conjugated with polymer dextran
marked with peroxidase (Dako EnVision Labelled Poly-
mer; Dako, Glostrup, Denmark). The reaction was de-
veloped with Permanent Red (Permanent Red Substrate
System, Dako) for the primary antibodies S-100, HMB-
45 and Melan-A, and diaminobenzidine hydrochloride
(DAB, Dako) was used as chromogen for Ki-67. The
preparations were lightly counterstained with Carazzi
hematoxylin, mounted with Aquatex (MERCK, Ger-
many) and examined by light microscope.
Antibody Clone Dilution Source
HMB-45 HMB-45 1:200 �ako®*
Melan-A A�03 1:800 �ako®*
Ki-67 M�B-1 1:100 �ako®*
�-100 Polyclonal 1:10.000 �ako®*
Table 1. Antibodies used for immunohistochemical evalua-
tion of 22 cases of primary oral melanomas.
*Dako, Dako Corporation, Carpinteria, California.
Fig. 1. Clinical aspects of primary oral melanoma. A. Oral melanoma of the hard palate showing a large black, irregular macula with
a small nodular area. B. Large pigmented melanoma of the lower gingiva causing tooth displacement.
3. Med Oral Patol Oral Cir Bucal. 2012 May 1;17 (3):e383-8. Primary oral melanoma
e385
The intensity of staining for S-100, HMB-45 and Me-
lan-A was graded as follows: negative (-); weak (+) 1%
to 25%; moderate (++) 25% to 50%; and strong (+++)
50% to 100% of the neoplastic cells. To calculate the
labeling index (LI) for Ki-67, 1000 tumor cells were
counted for each case and the results were expressed in
percentage of positive cells.
Results
Twenty out of 22 primary oral melanomas studied were
melanotic, and only two were amelanotic. Fifteen cases
(68.18%) showed deep cellular invasion (level III) when
diagnosed, while 4 and 2 cases presented levels II and I
respectively, and only one case was classified as in situ.
Cellular morphology varied, with 8 cases formed by epi-
thelioid and one by spindle cells, while the other 13 cases
showedamixedpopulationofepithelioidandplasmacytoid
or spindle cells. Most cases showed a predominant cellu-
lar solid pattern (17 cases-77.27%), followed by alveolar (3
cases), with organoid and pagetoid pattern in only one case
each. Necrosis, perivascular and perineural invasion was
found in 6, 7 and 3 cases respectively (Fig. 2).
Fig. 2. Histological aspects of primary oral melanoma (H&E). A. Oral melanoma of the hard palate composed mainly by
amelanotic spindle cells (x200). B. Oral melanoma of the upper gingiva formed by epithelioid and plasmacytoid neoplastic
melanocytes (x400). C. Solid OM showing nodular pattern of neoplastic melanocytic cells (x25). D. Epithelioid and plasma-
cytoid neoplastic melanocytes arranged in organoid pattern (x100). E. In situ lesion with neoplastic melanocytes arranged in
pagetoid pattern (x100). F. Oral melanoma of the hard palate showing perivascular invasion (x400).
4. Med Oral Patol Oral Cir Bucal. 2012 May 1;17 (3):e383-8. Primary oral melanoma
e386
Immunostaining with three melanocytic markers S-100,
HMB-45 and Melan-A in melanoma cells was cytoplas-
mic, but nuclear staining was also noted with S-100.
S-100 and HMB-45 were expressed in all cases, while
Melan-A was negative in 3 cases. S-100 was positive in
more than 50% of tumor cells in all cases, and HMB-45
had a strong staining in 21 cases (95.45%), and in one it
was moderate. Melan-A was expressed in 19 out of 22
cases; in 16, one and 2 cases it was strong, moderate and
weak respectively. Cell proliferation with Ki-67 ranged
from 15.51% to 63% of positive cells (Fig. 3).
(13,23,24), but information of histological and immuno-
histochemical profile is scarce.
Different from the skin there is not a definitive clinico-
pathological classification of OM (10,12,23). Classifica-
tion and staging of cutaneous melanomas using Bres-
low and Clark levels cannot be applied to oral mucosa
tumors due to structural differences between skin and
mucosa (13,25). In fact OM differ from cutaneous in
several aspects, including risk factors as actinic radia-
tion, a family history and association with atypical nevi,
factors applied mainly to cutaneous melanoma (4). In
Fig. 3. Expression of S-100 (A), HMB-45 (B), Melan-A (C), and Ki-67 (D) in primary oral melanoma of hard palate and upper gingiva (x400).
Discussion
Primary OM is a rare neoplasm accounting for only
0.5% of all oral malignances, with an incidence of 1.2
cases per 10 million per year (4,10,13). As it is very rare,
there are few reported series of OM. It is considered that
in Europe and Australia the incidence of OM is lower
than in Japan and in other nonwhite populations like in
Uganda, India and North American Indian (2, 6-8). Se-
ries of OM cases in Latin America have been reported
our present study we used the histological classification
proposed by Prasad et al. (26) based on the level of cel-
lular invasion. As noted previously, in contrast to cuta-
neous melanomas where the majority are diagnosed in
the radial growth phase, OM are found predominantly
in the vertical growth phase (4,12). Most cases in our
study were diagnosed with deep invasion (level III)
and only one as in situ. Although lesions in the mouth
usually are easily visualized, particularly if pigmented,
5. Med Oral Patol Oral Cir Bucal. 2012 May 1;17 (3):e383-8. Primary oral melanoma
e387
most cases of OM are in advanced stages when diag-
nosed. Unfortunately, this is also true for oral squamous
cell carcinoma, despite extensive efforts for early de-
tection of this relatively common neoplasia. Our results
were similar to those found by Lourenço et al. (13), with
82.35% of the cases diagnosed as level III, with only one
case as level I. Oral melanomas have a poor prognosis,
and according to Prasad et al. (26) the most important
histopathological predictor is tumor histological level.
Presence of melanin was observed in 20 cases, as 2
were amelanotic. In fact, it is known that over 90% of
oral melanomas contain melanin that can be easily ob-
served in routine hematoxilin and eosin (5,27). Bachar
et al. (28) studied 61 cases of head and neck mucosal
melanoma finding 6 amelanotic cases (12.8%), similar
to the values found in our study.
Different cell types, showing epithelioid, spindle and
plasmacytoid morphology have been described in OM
(5,12,13). In our series epithelioid cells predominated
in most cases, either as a monomorphous or polymor-
phous infiltrate, usually mixed with plasmacytoid or
spindle cells. The type of cellular infiltrate seems to
have no impact in prediction of tumor behavior; how-
ever, Lourenço et al. (13) observed in their series that
polymorphous tumors had a slightly higher incidence
of vascular infiltration and necrosis. Primary OM are
composed of nests or sheets of malignant cells in solid,
alveolar or organoid patterns, as found in our series
where the solid pattern (77.27%) predominated. As for
the cell type, the cellular pattern also does not seem to
influence the prognosis (5,12,13).
Vascular and perineural invasion was seen in 7 and 3
cases respectively, and similar results were described
by Lourenço et al. (13), who identified 45.71%, 60.61%
and 25.71% of cases with necrosis, perivascular and
perineural invasion respectively. It is interesting that
vascular invasion is more common than perineural, dif-
ferent from other more common oral tumors, as carci-
nomas and adenocarcinomas such as adenoid cystic car-
cinoma and polymorphous low-grade adenocarcinoma.
Although not commonly observed, and therefore not
considered to be an independent factor in most prognos-
tic models, vascular invasion when present in cutaneous
melanoma appears to be associated with a worse prog-
nosis (14). As suggested by Prasad et al. (29) presence
of vascular invasion potentially is an important indica-
tor of poor prognosis in OM, as this is the first step for
regional and distant metastases.
It is important to determine whether OM is a primary
or metastatic lesion. Clinical and microscopical char-
acteristics should be considered as site of involvement,
presence or absence of pigmentation, overlying mucosal
ulceration, extension along salivary glands ducts, and
vascular and perineural invasion (4,6). Pigmented le-
sions involving the palate and gingiva, with ulcerated
mucosa and extension along minor salivary gland are
common findings in primary OM. On the other hand
involvement of base of tongue with intact overlying
mucosa, palatal and gingival sparing, vascular and
perineural invasion are more commonly seen in meta-
static melanoma (4,6).
It is well known that melanoma has a wide spectrum
of histological features which mimic epithelial, hema-
tological, mesenchymal and neural tumors, and when
necessary immunohistochemistry is the primary tool to
establish the correct diagnosis (14-16, 30). Yu et al. (17)
studied the expression of melanocytic differentiation
markers in 6 primary OM. They showed that HMB-45,
S-100 and Melan-A were positive in 100%, 83% and 67%
of the cases respectively, suggesting that both HMB-45
and S-100 are good markers for immunohistochemical
diagnosis of primary OM. In this study, we found that
S-100 was a more sensitive marker than HMB-45 and
Melan-A, although it is much less specific. On the other
hand Prasad et al. (16) found that in sinonasal and OM
the least sensitive marker was HMB-45, marking 85%
of the cases, while S-100 and Melan-A were positive in
about 95% of the cases. In cutaneous melanomas, S-100
is the most sensitive marker with expression in about
98% of cases, but again it is the least specific (14-17).
HMB-45 and Melan-A show similar specificity in cu-
taneous melanomas with expression varying from 77-
100% (14-17, 20). Ki-67 staining is reported as positive
in 13-30% of the cells in cutaneous melanoma, although
individual cases can show almost 100% of nuclear posi-
tivity (14,15,31). In our study Ki-67 showed proliferat-
ing index ranging from 15.51% to 63% of positive cells.
The present study did not consider treatment and prog-
nosis of OM, but it is well established that treatment is
surgical with a very poor prognosis, with 1 and 5 years
survival of 75% and 15% respectively (4).
In summary, primary OM is rare, occurs in adult and
elderly patients and usually are diagnosed at advanced
stages, with very poor prognosis. It is formed by epi-
thelioid, spindle, plasmacytoid or a mixture of these
cells arranged in solid, alveolar and pagetoid pattern.
S-100 and HMB-45 are more frequently expressed than
Melan-A and these markers are helpful to confirm the
diagnosis.
References
1. Femiano F, Lanza A, Buonaiuto C, Gombos F, Di Spirito F, Cirillo
N. Oral malignant melanoma: a review of the literature. J Oral Pathol
Med. 2008;37:383-8.
2. Hashemi Pour MS. Malignant melanoma of the oral cavity: a re-
view of literature. Indian J Dent Res. 2008;19:47-51.
3. Gu GM, Epstein JB, Morton TH. Intraoral melanoma: long-term
follow-up and implication for dental clinicians. A case report and lit-
erature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
2003;96:404-13.
4. Hicks MJ, Flaitz CM. Oral mucosal melanoma: epidemiology and
pathobiology. Oral Oncol. 2000;36:152-69.
6. Med Oral Patol Oral Cir Bucal. 2012 May 1;17 (3):e383-8. Primary oral melanoma
e388
5. Meleti M, Leemans CR, Mooi WJ, Vescovi P, van der Waal I.
Oral malignant melanoma: a review of the literature. Oral Oncol.
2007;43:116-21.
6. Rapini RP, Golitz LE, Greer RO Jr, Krekorian EA, Poulson T. Pri-
mary malignant melanoma of the oral cavity. A review of 177 cases.
Cancer. 1985;55:1543-51.
7. Wagner M, Morris CG, Werning JW, Mendenhall WM. Mucosal
melanoma of the head and neck. Am J Clin Oncol. 2008;31:43-8.
8. Manolidis S, Donald PJ. Malignant mucosal melanoma of the head
and neck: a review of the literature and report of 14 patients. Cancer.
1997;80:1373–86.
9. Umeda M, Komatsubara H, Shigeta T, Ojima Y, Minamikawa T,
Shibuya Y, et al. Treatment and prognosis of malignant melanoma
of the oral cavity: preoperative surgical procedure increases risk of
distant metastasis. Oral Surg Oral Med Oral Pathol Oral Radiol En-
dod. 2008;106:51-7.
10. Garzino-Demo P, Fasolis M, Maggiore GM, Pagano M, Berrone
S. Oral mucosal melanoma: a series of case reports. J Craniomaxil-
lofac Surg. 2004;32:251-7.
11. Younes MN, Myers JN. Melanoma of the head and neck: current
concepts in staging, diagnosis, and management. Surg Oncol Clin N
Am. 2004;13:201-29.
12. Barker BF, Carpenter WM, Daniels TE, Kahn MA, Leider
AS, Lozada-Nur F, et al. Oral mucosal melanomas: the WESTOP
Banff workshop proceedings. Western Society of Teachers of Oral
Pathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
1997;83:672–9.
13. Lourenço SV, A MS, Sotto MN, Bologna SB, Giacomo TB, Buim
ME, et al. Primary oral mucosal melanoma: a series of 35 new cases
from South America. Am J Dermatopathol. 2009;31:323-30.
14. Banerjee SS, Harris M. Morphological and immunophenotypic
variations in malignant melanoma. Histopathology. 2000;36:387-
402.
15. Ohsie SJ, Sarantopoulos GP, Cochran AJ, Binder SW. Im-
munohistochemical characteristics of melanoma. J Cutan Pathol.
2008;35:433-44.
16. Prasad ML, Jungbluth AA, Iversen K, Huvos AG, Busam KJ.
Expression of melanocytic differentiation markers in malignant
melanomas of the oral and sinonasal mucosa. Am J Surg Pathol.
2001;25:782–7.
17. Yu CH, Chen HH, Liu CM, Jeng YM, Wang JT, Wang YP, et al.
HMB-45 may be a more sensitive maker than S-100 or Melan-A for
immunohistochemical diagnosis of primary oral and nasal mucosal
melanomas. J Oral Pathol Med. 2005;34:540-5.
18. Moore BW. A soluble protein characteristic of the nervous sys-
tem. Biochem Biophys Res Commun. 1965;19:739-44.
19. Salama I, Malone PS, Mihaimeed F, Jones JL. A review of the
S100 proteins in cancer. Eur J Surg Oncol. 2008;34:357-64.
20. Busam KJ. The use and application of special techniques in as-
sessing melanocytic tumours. Pathology. 2004;36:462-9.
21.Gown AM, Vogel AM, Hoak D, Gough F, McNutt MA. Mono-
clonal antibodies specific for melanocytic tumors distinguish sub-
populations of melanocytes. Am J Pathol. 1986;123:195-203.
22. Carlson JA, Ross JS, Slominski AJ. New techniques in dermat-
opathology that help to diagnose and prognosticate melanoma. Clin
Dermatol. 2009;27:75-102.
23. Lopez-Graniel CM, Ochoa-Carrillo FJ, Meneses-García A. Ma-
lignant melanoma of the oral cavity: diagnosis and treatment experi-
ence in a Mexican population. Oral Oncol. 1999;35:425-30.
24. Delgado-Azañero WA, Mosqueda-Taylor A. A practical meth-
od for clinical diagnosis of oral mucosal melanomas. Med Oral.
2003;8:348-52.
25. Chidzonga MM, Mahomva L, Marimo C, Makunike-Mutasa R.
Primary malignant melanoma of the oral mucosa. J Oral Maxillofac
Surg. 2007;65:1117-20.
26. Prasad ML, Patel SG, Huvos AG, Shah JP, Busam KJ. Primary
mucosal melanoma of the head and neck. A proposal for micro-
staging localized, stage I (lymphnode-negative) tumors. Cancer.
2004;100:1657–64.
27. Sortino-Rachou AM, Cancela Mde C, Voti L, Curado MP. Pri-
mary oral melanoma: Population-based incidence. Oral Oncol.
2009;45:254-8.
28. Bachar G, Loh KS, O’Sullivan B, Goldstein D, Wood S, Brown
D, et al. Mucosal melanomas of the head and neck: experience of the
Princess Margaret Hospital. Head Neck. 2008;30:1325-31.
29. Prasad ML, Patel S, Hoshaw-Woodard S, Escrig M, Shah JP,
Huvos AG, et al. Prognostic factors for malignant melanoma of
the squamous mucosa of the head and neck. Am J Surg Pathol.
2002;26:883-92.
30. Demierre MF, Sabel MS, Margolin KA, Daud AI, Sondak VK.
State of the science 60th anniversary review: 60 Years of advances
in cutaneous melanoma epidemiology, diagnosis, and treatment, as
reported in the journal Cancer. Cancer. 2008;1:1728-43.
31. Frahm SO, Schubert C, Parwaresch R, Rudolph P. High prolifera-
tive activity may predict early metastasis of thin melanomas. Hum
Pathol. 2001;32:1376-81.